Vidith Phillips, Director of Industry Relations at Hopkins Biotech Network, shared on LinkedIn:
“AI x Oncology: Research Highlights Shaping Cancer Care in 2025
Oncology is not just adopting AI, it is co-evolving with it. These studies reflect how deeply embedded AI has become in the cancer research pipeline and where it is starting to shape clinical care.
Key Takeaways :
- A multimodal GNN predicts chemotherapy response in bladder cancer (AUC 0.74) using pathology and gene expression
- LLM agents execute full scientific workflows with tool selection, reasoning, and self-correction
- A framework outlines 10 hallmarks of AI in oncology, from early screening to de novo drug design
- CNNs predict BRCA, HER2, and MSI from H&E slides, reaching clinical-grade accuracy in large cohorts
- AACR’s 2025 forecast emphasizes digital twins, spatial omics, and AI-guided treatment simulations
Save this roundup for reference.
How do you think AI will define cancer care in 2025?”
See more posts about AI in Oncology on OncoDaily.
